IEC 60601-2-23 Edition 3.0 2011-02

Standard Organization:

IEC 60601-2-23 Edition 3.0 2011-02
Medical electrical equipment - Part 2-23: Particular requirements for the basic safety and essential performance of transcutaneous partial pressure monitoring equipment

Recognition Date2012-08-20
Recognition List029
Recognition Number1-87
Extent Complete standard
Standards Orgs IEC International Electrotechnical Commission http://www.iec.ch/
STG Anesthesiology
FDA Tech  Neel Patel   FDA/OMPT/CDRH/ODE/DAGID/ANDB/   301-796-6274   Neel.Patel@fda.hhs.gov

Rationale:

This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.

Scope:

IEC 60601-2-23:2011 applies to the basic safety and essential performance of transcutaneous partial pressure monitoring equipment. It applies to transcutaneous monitors used with adults, children and neonates, and it includes the use of these devices in foetal monitoring during birth. IEC 60601-2-23:2011 does not apply to haemoglobin saturation oximeters or to devices applied to surfaces of the body other than the skin (for example conjunctiva, mucosa). This third edition cancels and replaces the second edition published in 1999 and constitutes a technical revision. This edition of IEC 60601-2-23 was revised to align structurally with the 2005 edition of IEC 60601-1.

Code of Federal Regulations:

Regulation Number Device Name Device Class Product Code
§868.2500 Monitor, Oxygen, Cutaneous, For Infant Not Under Gas Anesthesia Class 2 KLK
§868.2500 Monitor, Oxygen, Cutaneous, For Uses Other Than For Infant Not Under Gas Anesthesia Class 2 LPP
§868.2480 Monitor, Carbon-Dioxide, Cutaneous Class 2 LKD

FDA Guidance:

Class II Special Controls Guidance Document: Cutaneous Carbon Dioxide (PcCO2) and Oxygen (PcO2) Monitors; Guidance for Industry and FDA


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.